title: Activation of NK cells by an endocytosed receptor for soluble HLA-G.
abstract: Signaling from endosomes is emerging as a mechanism by which selected receptors provide sustained signals distinct from those generated at the plasma membrane. The activity of natural killer (NK) cells, which are important effectors of innate immunity and regulators of adaptive immunity, is controlled primarily by receptors that are at the cell surface. Here we show that cytokine secretion by resting human NK cells is induced by soluble, but not solid-phase, antibodies to the killer cell immunoglobulin-like receptor (KIR) 2DL4, a receptor for human leukocyte antigen (HLA)-G. KIR2DL4 was constitutively internalized into Rab5-positive compartments via a dynamin-dependent process. Soluble HLA-G was endocytosed into KIR2DL4-containing compartments in NK cells and in 293T cells transfected with KIR2DL4. Chemokine secretion induced by KIR2DL4 transfection into 293T cells occurred only with recombinant forms of KIR2DL4 that trafficked to endosomes. The profile of genes up-regulated by KIR2DL4 engagement on resting NK cells revealed a proinflammatory/proangiogenic response. Soluble HLA-G induced secretion of a similar set of cytokines and chemokines. This unique stimulation of resting NK cells by soluble HLA-G, which is endocytosed by KIR2DL4, implies that NK cells may provide useful functions at sites of HLA-G expression, such as promotion of vascularization in maternal decidua during early pregnancy.
authors.affiliation: Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.
authors.forename: Sumati
authors.initials: S
authors.lastname: Rajagopalan
authors.forename: Yenan T
authors.initials: YT
authors.lastname: Bryceson
authors.forename: Shanmuga P
authors.initials: SP
authors.lastname: Kuppusamy
authors.forename: Daniel E
authors.initials: DE
authors.lastname: Geraghty
authors.forename: Arnold
authors.initials: A
authors.lastname: van der Meer
authors.forename: Irma
authors.initials: I
authors.lastname: Joosten
authors.forename: Eric O
authors.initials: EO
authors.lastname: Long
mesh_terms: D018925:Chemokines / Q000096:biosynthesis; D016207:Cytokines / Q000096:biosynthesis; D034281:Dynamins / Q000494:pharmacology; D004705:Endocytosis / Q000502:physiology*; D006801:Humans; D016209:Interleukin-8 / Q000378:metabolism; D007694:Killer Cells, Natural / Q000187:drug effects / Q000502:physiology*; D008969:Molecular Sequence Data; D011971:Receptors, Immunologic / Q000502:physiology*; D054340:Receptors, KIR; D054345:Receptors, KIR2DL4; D054346:Receptors, KIR2DL5; D012995:Solubility; D015854:Up-Regulation; D020696:rab5 GTP-Binding Proteins / Q000502:physiology
chemical_list: D018925:Chemokines; D016207:Cytokines; D016209:Interleukin-8; C515079:KIR2DL4 protein, human; D011971:Receptors, Immunologic; D054340:Receptors, KIR; D054345:Receptors, KIR2DL4; D054346:Receptors, KIR2DL5; D020696:rab5 GTP-Binding Proteins; D034281:Dynamins